click below
click below
Normal Size Small Size show me how
CV 3-4
BDK
| Pharmacologic Category | Generic Name | Brand Name | Common Indications | Essential Knowledge |
|---|---|---|---|---|
| Omega-3 fatty acids | icosapent ethyl (PO) | Vascepa | Hypertriglyceridemia | Key Side Effects: eructation, arthralgia Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |
| Omega-3 fatty acids | omega-3 ethyl esters (PO) | Lovaza | Hypertriglyceridemia | Key Side Effects: dyspepsia, eructation, fishy aftertaste Other Notes: can prolong bleeding time when used with other medication that can increase bleeding risk, use caution with fish/shellfish allergy |
| HMG-CoA reductase inhibitorS | atorvastatin (PO) lovastatin (PO) pravastatin (PO) rosuvastatin (PO) simvastatin (PO) | Liptor Altoprev Pravachol Crestor Zocor | Dyslipidemia, CAD, stroke | Key Side Effects: myopathy/rhabdomyolysis Other Notes: avoid excessive grapefruit juice intake, avoid in pregnancy and breastfeeding |
| Fibric acid derivative | gemfibrozil (PO) | Lopid | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases |
| Fibric acid derivative | fenofibrate (PO) | Tricor, Trilipix | Hypertriglyceridemia | Key Side Effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases |
| Cholesterol absorption inhibitor | ezetimibe (PO) | Zetia | Dyslipidemia | Key Side Effects: myalgias, diarrhea |
| Antiarrhythmic | amiodarone (PO, IV) | Pacerone, Nexterone | Af (rhythm control), ventricular fibrillation, ventricular tachycardia | hypothyroidism, hyperthyroidism, pulmonary toxicity, hepatotoxicity, epithelial keratopathy, photosensitivity BW: intended only for life-threatening arrhythmias; pulmonary toxicity, hepatotoxicity; proarrhythmic Other Notes: many drug interactions |
| Fibrinolytic | alteplase (intracatheter, IV) | Intracatheter: Cathflo Activase, IV: Activase | Intracatheter: catheter clearance IV: STEMI, acute ischemic stroke, PE | Key Side Effects: bleeding Other Notes: CI in patients with severe uncontrolled HTN |
| Vasodilator | nitroglycerin (SL) | Nitrostat | ACS, stable angina | Key Side Effects: headache, flushing, syncope, dizziness Other Notes: do not use with PDE-5 Inhibitors; tachyphylaxis (tolerance/ ↓ effectiveness); can aggravate angina causes by hypertrophic cardiomyopathy |
| Antiplatelet agent | aspirin (PO) | Bayer, Bufferin, Ecotrin | ACS, stable angina, pain, stroke | Key Side Effects: dyspepsia, heartburn, bleeding Other Notes: CI in NSAID or salicylate allergy, children and teenagers with viral infection (due to Reye’s syndrome), can cause tinnitus in salicylate overdose |
| Antiplatelet agent | ticagrelor (PO) | Brilinta | ACS | Key Side Effects: bleeding, dyspnea US Boxed Warnings: significant, sometimes fatal bleeding; do not exceed aspirin >100 mg daily due to reduced ticagrelor effectiveness |
| Antiplatelet agent | clopidogrel (PO) | Plavix | CAD, stroke | Key Side Effects: bleeding US Boxed Warnings: diminished effectiveness in poor metabolizers |
| Anticoagulant | heparin (IV, SQ) | - | ACS, VTE | Key Side Effects: bleeding, hyperkalemia (chronic use), HIT |
| Anticoagulant, low molecular weight heparin | enoxaparin (SQ) | Lovenox | ACS, VTE | Key Side Effects: bleeding, HIT US Boxed Warnings: increased risk of epidural or spinal hematoma in patients undergoing spinal puncture Other Notes: do not expel air bubble from syringe prior to injection |
| Anticoagulant, vitamin K antagonist | warfarin (PO) | Coumadin, Jantoven | AF (stroke prevention), VTE | bleeding, skin necrosis BW:bleeding risk Other Notes: narrow therapeutic index drug (monitor INR) Other Notes: dose dependent tablet colors; consistent vitamin K intake recommended; many drug interactions |
| Anticoagulant, factor Xa inhibitor | rivaroxaban (PO) | Xarelto | AF (stroke prevention), VTE, PAD | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture |
| Anticoagulant, factor Xa inhibitor | apixaban (PO) | Eliquis | AF (stroke prevention), VTE | Key Side Effects: bleeding US Boxed Warnings: premature discontinuation increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patient undergoing spinal puncture |
| Anticoagulant, direct thrombin inhibitor | dabigatran (PO) | Pradaxa | AF (stroke prevention), VTE | bleeding, dyspepsia BW: premature d/c increases risk of thrombotic events; increased risk of epidural or spinal hematoma in patients undergoing spinal puncture swallow whole; dispense and store in original packaging; discard 4 months after opening |